|Bid||64.00 x 900|
|Ask||0.00 x 1300|
|Day's range||69.12 - 70.82|
|52-week range||61.05 - 78.38|
|Beta (3Y monthly)||1.05|
|PE ratio (TTM)||32.35|
|Earnings date||31 Jan 2019|
|Forward dividend & yield||0.76 (1.13%)|
|1y target est||75.29|
As art galleries adapt their models, so art fairs also have to change. That is the view supported by Anne Vierstraete, managing director of Art Brussels, who accordingly has created a new section for this ...
I am going to run you through how I calculated the intrinsic value of Baxter International Inc. (NYSE:BAX) by taking the expected future cash flows and discounting them to their Read More...
Intuitive Surgical's (ISRG) top line in the fourth quarter of 2018 is likely to benefit from solid grow that the Instruments and Accessories segment.
Will Restructuring Initiatives Put GE Back on Growth Trajectory? As part of its June 2018 major restructuring plan, General Electric (GE) intends to spin off the Healthcare segment and turn it into a standalone entity. The move is believed to be another step by newly appointed CEO Larry Culp to optimize the company’s business and strengthen its liquidity position.
Baxter (BAX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Dividends can be underrated but they form a large part of investment returns, playing an important role in compounding returns in the long run. Historically, Baxter International Inc. (NYSE:BAX) has Read More...
Mallinckrodt (MNK) and partner NPXe Limited enrol the first patient in the phase III study on xenon gas for inhalation (XENEX) for Post Cardiac Arrest Syndrome (PCAS).
NEW YORK, Dec. 20, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
Let's talk about the popular Baxter International Inc. (NYSE:BAX). The company's shares received a lot of attention from a substantial price movement on the NYSE over the last few months, Read More...
Medtronic’s (MDT) Cardiac & Vascular Group generated revenues of $2.9 billion in the second quarter of fiscal 2019 compared to $2.8 billion in the second quarter of fiscal 2018, reflecting ~3% YoY growth.
Why Has General Electric Stock Struggled in 2018? The Healthcare segment is the fourth-largest contributor to General Electric’s total revenues. As part of the company’s major restructuring plan in June, General Electric intends to spin off the segment and turn it into a standalone entity.
Today I will examine Baxter International Inc’s (NYSE:BAX) latest earnings update (30 September 2018) and compare these figures against its performance over the past couple of years, in addition to Read More...
In November, among the 22 analysts covering Edwards Lifesciences (EW), 13 recommended a “buy” or higher rating, seven recommended a “hold” rating, and two recommended a “sell” or lower rating. The mean rating for Edwards Lifesciences stock is 2.32 with a target price of $161.53, which implies an upside potential of 4.5% over Edwards Lifesciences’ closing price of $154.52 on November 27.
General Electric’s (GE) Healthcare segment, which offers medical imaging and information technologies, biopharmaceutical manufacturing technologies, and patient monitoring systems, is one of the company’s better-performing units and is the fourth-largest contributor to its total revenue.
In November, among the 17 analysts covering Baxter International (BAX), ten analysts recommended a “buy” or a higher rating, five recommended a “hold” rating, and three recommended a “sell” rating. The mean rating for Baxter International stock is 2.29 with a target price of $73.27, which implies an upside potential of 11.3% over Baxter International’s closing price of $65.83 on November 15.
Baxter International’s (BAX) net interest expense decreased from $14.0 million in the third quarter of 2017 to $11.0 million in the third quarter. The company’s net other income increased from $4.0 million in the third quarter of 2017 to $32.0 million in the third quarter. While the company incurred an income tax expense of $42.0 million in the third quarter of 2017, it received an income tax benefit of $138.0 million in the third quarter.